8-KEarnings & ResultsExhibits & Filings

Guardant Health, Inc. 8-K Report, Financial Results (Nov 5, 2020)

Filed November 5, 2020For Securities:GH

Summary

Guardant Health, Inc. filed an 8-K on November 5, 2020, to report its financial results for the fiscal quarter ended September 30, 2020. While the 8-K itself is brief and primarily incorporates a press release for the detailed financial information, investors should note that this filing signals the company's performance during the third quarter of 2020. The press release, furnished as Exhibit 99.1, contains the core financial data investors would be looking for, including revenue, net loss, and potentially key operational metrics relevant to the company's cancer screening and testing business. As this is a standard earnings release, the key takeaway for investors lies within the performance metrics disclosed in the accompanying press release. It's crucial for investors to review the actual press release (Exhibit 99.1) for specifics on revenue growth, the company's cash burn, progress in its clinical trials or product development, and any guidance provided for future periods. This 8-K serves as the official notification of these results being made public, initiating the period for further analysis and discussion around Guardant Health's financial health and strategic direction.

Key Highlights

  • 1Guardant Health announced its third quarter 2020 financial results on November 5, 2020, via an 8-K filing.
  • 2The core financial and operational details are provided in a press release furnished as Exhibit 99.1.
  • 3This filing marks the official disclosure of Q3 2020 performance.
  • 4Investors should refer to Exhibit 99.1 for specific financial metrics and performance indicators.
  • 5The 8-K itself does not contain the detailed financial statements but incorporates them by reference.
  • 6The information furnished is not deemed 'filed' for Section 18 purposes, a standard disclaimer for earnings releases.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Guardant Health, Inc.'s financial results for the fiscal quarter ended September 30, 2020, by incorporating a press release containing these details.

The detailed financial results are located in the press release furnished as Exhibit 99.1 to this 8-K filing. You will need to access Exhibit 99.1 for the specific revenue, net income/loss, and other key performance indicators.

No, the 8-K filing itself does not include the detailed financial statements. It only references and incorporates by reference the press release (Exhibit 99.1) which contains the summary financial results and potentially key operational data.

The disclaimer signifies that the information furnished in this report, including the press release, is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This generally means the company will not be subject to the liabilities associated with that section for this specific disclosure, which is standard practice for earnings press releases furnished under Item 2.02.